Evaluation of the Efficacy of Rapamycin and a Dipeptidyl Peptidase-4 Inhibitor (Vildagliptin) in Improving Beta Cell Function in Type 1 Diabetes of Long Duration, a Perspective Randomized Study
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Sirolimus (Primary) ; Vildagliptin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms MONORAPA
- 07 Feb 2018 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.
- 07 Feb 2018 Planned primary completion date changed from 1 May 2018 to 1 Dec 2018.
- 01 Jul 2016 New trial record